Saturn V Capital Management »

Mbx Biosciences shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $332k 18k 18.43

More positions owned by Saturn V Capital Management

Abivax Sa Sponsored Ads (ABVX)
Amylyx Pharmaceuticals (AMLX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Dyne Therapeutics (DYN)
Cogent Biosciences (COGT)
Vaxcyte (PCVX)
Celcuity (CELC)
Cg Oncology (CGON)
Disc Medicine (IRON)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Merus N V (MRUS)
Lenz Therapeutics (LENZ)
Ocular Therapeutix (OCUL)

View all positions for Saturn V Capital Management

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
Wellington Management Company
OrbiMed Advisors
NEA Management Company
Deep Track Capital
NVP Associates
EcoR1 Capital
Kynam Capital Management
BlackRock
Vanguard Group
Driehaus Capital Management
Franklin Resources
Cormorant Asset Management
Woodline Partners
Citadel Advisors

View all funds holding Mbx Biosciences